Agno Pharmaceuticals is a global small molecule CDMO supplying critical RSMs, intermediates, active pharmaceutical ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations to large and medium-sized pharmaceutical, biotech, generic and CDMO customers. Founded in 2004, Agno has a process development and US-FDA-inspected GMP-compliant manufacturing facilities with sterile suspension injectable manufacturing capabilities. In addition, Agno has established a drug pr...oduct formulation research and development laboratory for complex injectables. Agno Pharmaceuticals has invested in its people and facilities and established a broad spectrum of service capabilities throughout drug development and commercialization.
